Efficacy of Tegoprazan for Improving the Susceptibility of Antimicrobial Agents against Antibiotic-Resistant Helicobacter pylori

BACKGROUND/AIMS: Favorable outcomes of potassium-competitive acid blocker (PCAB)-containing eradication therapy have been reported. In fact, tegoprazan, a recently developed PCAB, was presumed to show good eradication efficacy even for resistant Helicobacter pylori. We aimed to investigate the anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jung Won, Kim, Nayoung, Nam, Ryoung Hee, Yu, Jeong Eun, Son, Joo Hee, Lee, Sun Min, Lee, Dong Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817939/
https://www.ncbi.nlm.nih.gov/pubmed/33191308
http://dx.doi.org/10.5009/gnl20247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817939/
https://www.ncbi.nlm.nih.gov/pubmed/33191308
http://dx.doi.org/10.5009/gnl20247

Ejemplares similares